TopStockBD
DSE TodayToday's prices & moversToday's NewsAll company news, last dayMarket AnalysisPulse, sentiment, trendsDSE Top 20Momentum leadersPopular StocksMost-traded today
TopStock AIChat: picks, market & answersRankingsScored leaderboardDaily TipsFresh signals every dayFind My StocksPersonalized pickerStock ListsReady-made listsBrowse All StocksFull A–Z table
BlogsEnglish guidesবাংলা ব্লগBangla guidesBehind the ScoreHow we rank stocks
WatchlistPortfolioPrice AlertsSign InSign Up
Menu
MarketsDSE TodayToday's NewsMarket AnalysisDSE Top 20Popular Stocks
DiscoverTopStock AIRankingsDaily TipsFind My StocksStock ListsBrowse All Stocks
LearnBlogsবাংলা ব্লগBehind the Score
YouWatchlistPortfolioPrice AlertsSign InCreate Account
TopStockBD

Fundamental scoring for Dhaka's market

[email protected]

Explore

  • Stock Rankings
  • Market Analysis
  • DSE Today
  • Browse Stocks
  • Stock Lists

Learn

  • Beginner's Guide
  • বাংলা ব্লগ
  • Watchlist
  • Portfolio
  • Behind the Score

Company

  • About Us
  • Contact
  • Privacy Policy
  • Disclaimer

TopStockBD covers DSE share price today, Dhaka Stock Exchange (DSEX) live data, Bangladesh stock market rankings, DSE news, BD stock market signals, and DSE share price list — free fundamental analysis for every listed company. Learn how to invest in DSE, how to buy shares in Bangladesh, how to open a BO account, find best stocks in Bangladesh, dividend stocks, blue chip stocks Bangladesh, and undervalued stocks DSE using P/E ratio and fundamental analysis.

© 2026 TopStockBD. All rights reserved.

Not investment advice. For informational purposes only.

HomeDSEDiscoverWatchlist
  1. Home
  2. /
  3. Rankings
  4. /
  5. SQURPHARMA

Square Pharmaceuticals PLC.

SQURPHARMAPharmaceuticals & ChemicalsCategory A

Last Price

221.0৳
▼-0.76% today
Low ৳198.3In its normal rangeHigh ৳232.2

Where today's price sits in its 52-week range

The Price Story

এক নজরে

Square Pharmaceuticals PLC. ওষুধ ও রসায়ন খাতের একটি কোম্পানি। সব মিলিয়ে এটি একটি শক্তিশালী কোম্পানি (আমাদের বিশ্লেষণে 100-এর মধ্যে 82)। কোম্পানিটি লাভজনক। একই ধরনের অন্যান্য কোম্পানির তুলনায় এই শেয়ারটির দাম এখন তুলনামূলক কম। কোম্পানিটি ভালো ডিভিডেন্ড দেয় — বর্তমান দামে বছরে প্রায় 5.4% রিটার্ন আসে।

এটি শিক্ষামূলক তথ্য, বিনিয়োগ পরামর্শ নয়।

SQURPHARMAStrong Buy 82
Rank #5 of 361Hold for the long runLong-term hold
৳221-0.8%
VerdictHealthValueNumbersFinancialsMomentumSignalsPeersOwnersNews
TopStockBDAnalysis

Square Pharmaceuticals PLC.

SQURPHARMAPharmaceuticals & ChemicalsLatest Price: ৳221.0
Fundamental Score
82/ 100

Strong Buy

Long-term hold

Strong company, but market hasn't noticed yet

  • The company has strong profits and a healthy balance sheet, but the share price has not moved for weeks. Patient long-term investors may benefit if the market wakes up to it later.
  • Has paid dividends regularly in past years.
  • The share price looks cheaper now than its average over the past few years.
topstockbd.comDSE Stock Analysis
⭐

Featured in our stock lists

🏆Best DSE Stocks 2026#5🏆Most Profitable Companies#2🇧🇩Top Stocks 2025#2💊Best Pharma Stocks#3📈Highest EPS Stocks#10

The Health Check

Five quick checks that tell you whether this company is healthy, fairly priced, and worth holding.

Is the Price Right?

Looks cheap right now — priced below its usual level.

P/E Ratio

8.2

Price per ৳1 of yearly earnings

Dividend Yield

5.40%

Annual cash return on the price

P/B Ratio

1.4

Price per ৳1 of net assets

Trading at 8.2 — below its 5-year average of 9.8.

Key Numbers

The raw figures behind the verdict — for the curious.

EPS

৳27.04

Earnings per share (latest year)

P/E Ratio

7.7

Price you pay per ৳1 of earnings

Dividend Yield

5.40%

Annual cash return on the price

Reserve & Surplus

৳12,905 Cr

Company's accumulated savings

Total Loan

৳82.5 Cr

Outstanding debt the company carries

Profits & Dividends

Are they making money — and do they share it with shareholders?

Yearly Profit

Net profit per year

Made a profit every year for 5 years.

Earnings Per Share

Profit you earn per share

Earnings per share have been growing — ৳27.0 latest.

Yearly Cash Dividend

% of face value

📢 New 120% dividend just declared — record 16 Nov 2025

Paid a dividend every year for 5 years running.

The deeper numbers — revenue, margins, debt and cash quality over the years.

Recent Momentum

What the share price has been doing over the last week.

Flat

Down 1.3% in the past week, lagging the overall market.

Past week

-1.3%

Price move over 7 days

Vs market

-2.0%

Ahead/behind the DSEX index

Trading volume

1.1×

vs its normal volume

Up days

2/7

Green days this week

52-week spot

67%

Position in 1-year range

Trades around ৳12.8 Cr a day on average over the past week.

Signals at a Glance

The good signs and the things to keep an eye on.

Good signs

  • ✓Made profits in 4 out of the last 5 years
  • ✓Generates real cash from its day-to-day business
  • ✓Pays a dividend every year, like clockwork
  • ✓Currently priced cheaper than its own history

How It Stacks Up

SQURPHARMA scores higher than 4 of 5 top sector peers shown below.

Stock
MARICO84৳2,731+0.1%14.6+14.1%+78.4%
SQURPHARMA82৳221-0.8%8.2+5.4%+14.8%
KOHINOOR78৳513+0.9%30.1+1.3%+26.2%
RECKITTBEN74৳3,326+0.2%19.2+5.2%+45.4%
ACMELAB73৳84.5+0.4%7.4+4.1%+9.1%
NAVANAPHAR72৳73.3+1.5%16.1+1.9%+8.9%

Who Owns It

Who's behind this company — and how committed are they? As of Mar 2026, compared with Jun 2025.

Owners (Sponsors / Directors)▲ 0.644.1%
Institutions▼ 0.413.6%
Foreign Investors15.3%
General Public26.9%

Good sign — owners (sponsors) raised their stake from 43.6% to 44.1% since Jun 2025. People close to the company are buying.

Owners (sponsors) hold 44% — a strong sign of commitment.

What's New

Recent news and announcements about this company.

The company has informed that the Board of Directors of the company in its meeting held on 28 June 2026 has approved agreements with M/s C2C Pharma Ltd., Dhaka, Bangladesh for contract manufacturing of some products on behalf of Square Pharmaceuticals PLC. to meet increased demand of existing products and to introduce new products. It is mentionable that DSE has requested the company to provide copy of the agreement; however, DSE is yet to receive the copy of the agreement.
(Q3 Un-audited): Consolidated EPS was Tk. 6.73 for January-March 2026 as against Tk. 6.83 for January-March 2025; Consolidated EPS was Tk. 23.29 for July 2025-March 2026 as against Tk. 21.15 for July 2024-March 2025. Consolidated NOCFPS was Tk. 17.54 for July 2025-March 2026 as against Tk. 11.90 for July 2024-March 2025. Consolidated NAV per share was Tk. 169.79 as on March 31, 2026 and Tk. 157.88 as on June 30, 2025. (cont.)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2026 at 3:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.